Novo Nordisk offers free 90 day insulin supply to people experiencing financial hardship due to COVID-19

Novo Nordisk

14 April 2020 - People with diabetes using Novo Nordisk insulin who have lost health insurance coverage because of a change in job status due to the COVID-19 pandemic may now be eligible for enrollment in our Diabetes Patient Assistance Program (PAP) and receive insulin free of charge for 90 days.

Through this enhancement, applicants are not required to provide documented proof of income. Participants must provide documentation showing loss of healthcare benefits, such as a job termination notice or job status change, or proof that COBRA benefits are being offered. 

In addition, if Medicaid benefits are denied, assistance for eligible patients can be extended past the 90-day-window until the end of the year. 

Read Novo Nordisk press release

Michael Wonder

Posted by:

Michael Wonder